Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

241 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q2 2017.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 38,446,334 shares of 62,650,155 outstanding shares and own 61% of the company stock.
Largest 10 shareholders include FMR LLC (5,601,943 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,538,873 shares), BlackRock Inc. (3,031,548 shares), VANGUARD GROUP INC (2,749,954 shares), Bank of New York Mellon Corp (1,985,533 shares), OppenheimerFunds, Inc. (1,785,640 shares), WELLINGTON MANAGEMENT GROUP LLP (1,584,449 shares), STATE STREET CORP (1,212,384 shares), JENNISON ASSOCIATES LLC (1,089,528 shares), and Palo Alto Investors, LLC (1,033,025 shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.